| 000 | 01007 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512082239.0 | ||
| 264 | 0 | _c19850327 | |
| 008 | 198503s 0 0 eng d | ||
| 022 | _a0008-4409 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurdge, D R | |
| 245 | 0 | 0 |
_aNeurotoxic effects during vidarabine therapy for herpes zoster. _h[electronic resource] |
| 260 |
_bCanadian Medical Association journal _cFeb 1985 |
||
| 300 |
_a392-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Arrest _xetiology |
| 650 | 0 | 4 |
_aHerpes Zoster _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPain _xchemically induced |
| 650 | 0 | 4 |
_aPneumonia, Aspiration _xcomplications |
| 650 | 0 | 4 |
_aTremor _xchemically induced |
| 650 | 0 | 4 |
_aVidarabine _xadverse effects |
| 700 | 1 | _aChow, A W | |
| 700 | 1 | _aSacks, S L | |
| 773 | 0 |
_tCanadian Medical Association journal _gvol. 132 _gno. 4 _gp. 392-5 |
|
| 999 |
_c3976942 _d3976942 |
||